Lataa...
Delafloxacin: First Global Approval
Delafloxacin (Baxdela™) is a fluoroquinolone antibacterial with activity against both gram-positive and gram-negative pathogens being developed by Melinta Therapeutics. The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in...
Tallennettuna:
| Julkaisussa: | Drugs |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6208769/ https://ncbi.nlm.nih.gov/pubmed/28748399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0790-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|